ClinicalTrials.Veeva

Menu

Exploring Long-term Risks and STI Prevalence in Pre-Exposure Prophylaxis Users in Gironde, France (SAFER-PrEP)

U

University Hospital of Bordeaux

Status

Completed

Conditions

Sexually Transmitted Diseases
HIV Infections

Treatments

Behavioral: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT06600087
CHUBX 2024/03

Details and patient eligibility

About

SAFER-PrEP investigates the long-term impact of Pre-Exposure Prophylaxis (PrEP) on risky sexual behaviors and Sexually Transmitted Infection (STI) prevalence among users in Aquitaine. The study aims to compare STI rates over the last three months between individuals on PrEP for over a year and those on PrEP for less than a year. This retrospective observational research offers insights into the evolving dynamics of sexual health practices, informing future PrEP prescriptions and enhancing preventive strategies.

Full description

Scientific Rationale: The SAFER-PrEP study stems from the imperative to comprehend the intricate interplay between Pre-Exposure Prophylaxis (PrEP) utilization and sexual health dynamics. Amidst the increasing adoption of PrEP for HIV prevention, concerns arise regarding potential behavioral shifts and heightened risks for Sexually Transmitted Infections (STIs). The comprehensive investigation into these phenomena seeks to provide nuanced insights into the long-term implications of PrEP, contributing valuable data to public health initiatives and refining prevention strategies in the face of evolving sexual health landscapes.

Procedure: Participants, comprising individuals on PrEP for over a year and those for less than a year, will be engaged through a observational approach. Data will be collected via self-administered questionnaires during routine consultations for PrEP renewal in various medical settings, including hospitals and private practices. This comprehensive strategy enables a nuanced exploration of sexual behaviors and STI prevalence.

Enrollment

248 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged over 18 years old;
  • Participants using PrEP for at least 6 months ;
  • French-speaking, without comprehension disorders ;
  • being affiliated to health insurance ;
  • Willing to participate and to sign informed consent.

Exclusion criteria

  • Individuals with known HIV positivity;

Trial design

248 participants in 2 patient groups

PrEP less than a year
Treatment:
Behavioral: Questionnaire
PrEP for over a year
Treatment:
Behavioral: Questionnaire

Trial contacts and locations

8

Loading...

Central trial contact

Maïa YAKOUB-AGHA; Jean-Philippe JOSEPH, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems